Varenicline in smokers with severe or very severe COPD after 24 weeks of treatment. A descriptive analysis: VALUE study

Varenicline in smokers with severe or very severe COPD after 24 weeks of treatment. A descriptive analysis: VALUE study

A large number of COPD patients are smokers. The particular characteristics of this group as well as their need to quit usually require psychological counselling and pharmacological treatment to achieve abstinence and, often, intensively. Little information is available about this issue.  The main...

Full description

Bibliographic Details
Main Authors: Carlos A. Jiménez-Ruiz, Marcos Garcia Rueda, Manuel A. Martinez Muñiz, Jacobo Sellarés, Maria A. Jiménez-Fuentes, Lourdes Lázaro Asegurado, Esther Rodríguez Gonzalez, Concepción Rodriguez Garcia, Oriol Armengol, Emilia Abad, Teresa Peña, Adolfo Domenech del Rio, Juan A. Riesco Miranda
Format: Article
Language:English
Published: PAGEPress Publications 2017-12-01
Series:Monaldi Archives for Chest Disease
Subjects:
COPD
smoking cessation
Varenicline.
Online Access:https://www.monaldi-archives.org/index.php/macd/article/view/874

Internet

https://www.monaldi-archives.org/index.php/macd/article/view/874

Similar Items